ARTICLE | Clinical News
10% high purity intravenous immunoglobulin: Phase III started
February 22, 2010 8:00 AM UTC
Octapharma began an international Phase III trial to evaluate 10% high purity IVIG. The company's octagam, a 5% IVIG, is marketed in about 60 countries worldwide. ...